Growing community of inventors

Durham, NC, United States of America

Christopher M O'Connor

Average Co-Inventor Count = 3.72

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 30

Christopher M O'ConnorPaul A Gurbel (2 patents)Christopher M O'ConnorVictor L Serebruany (2 patents)Christopher M O'ConnorCathleen S Colon-Emeric (2 patents)Christopher M O'ConnorKenneth W Lyles (2 patents)Christopher M O'ConnorRichard S Stack (1 patent)Christopher M O'ConnorColleen Stack (1 patent)Christopher M O'ConnorHoward A Rockman (1 patent)Christopher M O'ConnorDennis Abraham (1 patent)Christopher M O'ConnorIndira Varia (1 patent)Christopher M O'ConnorKrishnaswamy Ranga Krishnan (1 patent)Christopher M O'ConnorKent Nilsson (1 patent)Christopher M O'ConnorGraham Russell (1 patent)Christopher M O'ConnorColleen Stack-D'NIAYE (0 patent)Christopher M O'ConnorChristopher M O'Connor (5 patents)Paul A GurbelPaul A Gurbel (14 patents)Victor L SerebruanyVictor L Serebruany (5 patents)Cathleen S Colon-EmericCathleen S Colon-Emeric (2 patents)Kenneth W LylesKenneth W Lyles (2 patents)Richard S StackRichard S Stack (104 patents)Colleen StackColleen Stack (3 patents)Howard A RockmanHoward A Rockman (3 patents)Dennis AbrahamDennis Abraham (1 patent)Indira VariaIndira Varia (1 patent)Krishnaswamy Ranga KrishnanKrishnaswamy Ranga Krishnan (1 patent)Kent NilssonKent Nilsson (1 patent)Graham RussellGraham Russell (1 patent)Colleen Stack-D'NIAYEColleen Stack-D'NIAYE (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Duke University (3 from 2,020 patents)

2. Heartdrug Research, L.l.c. (2 from 4 patents)


5 patents:

1. 9949992 - Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction

2. 9867838 - Methods for treating heart failure using bisphosphonate compositions

3. 6552014 - Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors

4. 6316469 - Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease

5. 6245782 - Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…